SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001358403-18-000031
Filing Date
2018-02-23
Accepted
2018-02-23 16:09:45
Documents
3
Period of Report
2018-02-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K a8-kdirectorxedharrigan.htm 8-K 36368
2 EXHIBIT 99.1 exh991-pressreleaseedmundh.htm EX-99.1 10745
3 exh991pressreleaseedm_image1.jpg GRAPHIC 27677
  Complete submission text file 0001358403-18-000031.txt   86651
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 18636624
SIC: 2834 Pharmaceutical Preparations